ArticleBioinformation2026
Serum lipid profile as an indicator of disease severity in chronic liver disease: A hospital-based cross-sectional study.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic liver disease (CLD) is associated with significant metabolic alterations, particularly affecting lipid synthesis and regulation, making serum lipid levels potential indicators of disease severity. This cross-sectional, hospital-based study enrolled 120 adult CLD patients (≥18 years) of diverse etiologies, viral hepatitis B/C, alcoholic liver disease and non-alcoholic fatty liver disease (NAFLD)-to evaluate associations between serum lipid parameters and liver dysfunction. Fasting total cholesterol, LDL, HDL and triglycerides were measured and composite lipid scores were derived and analyzed against Child-Pugh classification using ANOVA, correlation and chi-square tests. Total cholesterol, LDL and HDL significantly declined with increasing Child-Pugh class (p < 0.001; η
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.